These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10731955)

  • 1. [Myelogenous system cells' activity in the bone marrow in children with acute leukemia remission].
    Rybczyńska J; Sikorska-Fic B; Wasik M; Rokicka-Milewska R
    Wiad Lek; 1998; 51 Suppl 4():124-8. PubMed ID: 10731955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow in children with acute leukosis during a period of remission].
    Khokhlova RN; Schastlivtseva LP
    Arkh Patol; 1969; 31(12):42-6. PubMed ID: 5267794
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
    Iversen PO; Wiig H
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia.
    Shi JM; Huang H; Chen QF; Lin MF
    J Zhejiang Univ Sci B; 2006 Feb; 7(2):154-8. PubMed ID: 16421973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy.
    Tunç B; Oner AF; Hiçsönmez G
    Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of glutathione S-transferase and lung resistance-related proteins in acute leukemia and its clinical significance].
    Zhang ZM; Xie ZX; Tan DR; Huang CH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):292-4. PubMed ID: 16045016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia.
    Chow LM; Chui CH; Tang JC; Teo IT; Lau FY; Cheng GY; Wong RS; Leung TW; Lai KB; Yau MY; Gou D; Chan AS
    Oncol Rep; 2003; 10(5):1601-7. PubMed ID: 12883747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
    Tallman MS; Pérez WS; Lazarus HM; Gale RP; Maziarz RT; Rowe JM; Marks DI; Cahn JY; Bashey A; Bishop MR; Christiansen N; Frankel SR; García JJ; Ilhan O; Laughlin MJ; Liesveld J; Linker C; Litzow MR; Luger S; McCarthy PL; Milone GA; Pavlovsky S; Phillips GL; Russell JA; Saez RA; Schiller G; Sierra J; Weiner RS; Zander AR; Zhang MJ; Keating A; Weisdorf DJ; Horowitz MM
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):204-16. PubMed ID: 16443518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow cultures in acute leukemia of childhood.
    Ragab AH; Kennedy MS; Findley HW; Lui VK
    Am J Pediatr Hematol Oncol; 1981; 3(4):419-24. PubMed ID: 7036782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report.
    Berger M; Ferrero I; Vassallo E; Gastaldo L; Carraro F; Biasin E; Madon E; Fagioli F
    Pediatr Hematol Oncol; 2005; 22(7):597-608. PubMed ID: 16166053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acute leukemia with allogeneic stem cell transplantation].
    Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
    Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
    Wu S; Korte A; Gessner R; Henze G; Seeger K
    Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.